Gram Research analysis of a 2026 case report found that a 9-year-old child with more than 17 muscle breakdown episodes carried a newly identified LPIN1 gene change, which likely contributed to the condition. Genetic testing was key to finding this cause, which can guide early treatment and prevention.
According to research reviewed by Gram, doctors found a rare gene change in a 9-year-old child from Syria who had more than 17 episodes of rhabdomyolysis, a serious condition in which muscles break down and release harmful substances into the blood. The episodes began around age 2 and brought severe headaches, vomiting, dark red urine, weakness in the hands and feet, and fever. Genetic testing found a new change in a gene called LPIN1, which helps the body use fat for energy. The child was treated with rest, fluids through a vein, and nutrition support. Because this report describes only one child, it cannot show how common this change is. It does show that genetic testing can help doctors find the cause of repeated muscle breakdown and plan ways to prevent future emergencies.
Key Statistics
A 2026 case report published in Medicine described a 9-year-old Syrian child with more than 17 episodes of rhabdomyolysis since age 2 and a new LPIN1 gene variant identified through whole-exome sequencing.
The report notes that LPIN1 mutations account for approximately 60% of recurrent pediatric rhabdomyolysis cases in Western cohorts, based on background research cited by the authors.
A single-patient case report published in 2026 identified a previously unreported homozygous LPIN1 variant, c.2362C>T, in a child with recurrent rhabdomyolysis.
The Quick Take
- What they studied: Doctors wanted to find out what caused one child’s repeated episodes of muscle breakdown, and whether a specific gene change could be the reason.
- Who participated: One child, a 9-year-old from Syria with no significant family medical history. The child had more than 17 episodes of muscle breakdown since age 2.
- Key finding: Genetic testing found a new change in the LPIN1 gene that appears to explain the child’s repeated episodes. Because only one patient was studied, the report cannot prove that this change causes the problem in other people, but it adds a new change to the known list of causes.
- What it means for you: If you or your child has repeated episodes of dark urine, severe muscle pain, or weakness, especially during illness, talk with a doctor about whether testing is needed. This finding does not mean that most people with muscle problems carry this change.
The Research Details
This is a case report, which means doctors carefully documented the medical history of one patient rather than comparing a large group of people. The team reviewed the child’s symptoms, past episodes, and treatment over many years, and recorded what happened during the current episode, which had lasted more than 2 weeks.
To look for the cause, the doctors used whole-exome sequencing. This is a genetic test that reads the parts of genes that give instructions for making proteins, where most known disease-causing changes are found. The test identified a change in the LPIN1 gene that the child carried in both copies of the gene.
The researchers then classified this change as likely disease-causing and described how it may affect the body. They also reported the child’s treatment and outcomes, including supportive care with rest, fluids, and nutrition.
Case reports are often the first step in discovering a new disease cause. When a rare change is found in one patient, it can alert other doctors to look for the same change in similar cases. A detailed record like this helps doctors understand how a gene change shows up in real life, even though it cannot tell them how often it occurs.
The report was published in a peer-reviewed journal, which means other experts reviewed it before publication. The genetic testing method is a standard tool used in clinical care and research. However, a single case has clear limits: there is no comparison group, no long-term follow-up is described, and the findings cannot be applied to whole populations. Readers should treat this as an important early observation rather than a settled rule.
What the Results Show
The child had a long history of rhabdomyolysis, with more than 17 episodes since age 2. Each episode brought severe headaches, vomiting, dark red urine, weakness in the hands and feet, and fever. The most recent episode had lasted more than 2 weeks, which shows how serious and long-lasting these attacks can be.
The genetic test found a change called c.2362C>T, which the report describes as creating a premature stop signal in the LPIN1 gene (written as p.Gln788*). In plain terms, the gene’s instructions appear to be cut short, so the body likely cannot make a fully working version of the lipin-1 protein. This protein helps the body break down fats for energy, and when it does not work well, muscles may struggle under stress from illness or lack of food.
The child was treated with rest, intravenous fluids, and nutrition support. The report notes that repeated episodes of muscle breakdown can place stress on the kidneys, which is why acute kidney injury was flagged as a possible complication. The case shows that prompt supportive care is important during these episodes.
The report also cites earlier research stating that LPIN1 changes account for about 60% of recurrent rhabdomyolysis cases in children in Western studies. This figure comes from background research described in the paper, not from the single child studied here.
The child’s symptoms, including dark red urine, vomiting, and fever, were consistent with muscle breakdown releasing proteins into the blood. Recognizing this pattern early matters because it can signal the need for urgent blood and kidney tests.
The child had no notable family history, even though the gene change was present in both copies. The report does not describe testing of the parents, but people who carry one copy of a change like this usually have no symptoms. Family testing could help clarify risk for other relatives, though the paper does not provide those details.
The finding also highlights that genetic testing can reveal a cause that might otherwise be missed when episodes come and go. Early identification may help the care team plan for future episodes.
LPIN1 is already known to be a leading genetic cause of recurrent rhabdomyolysis in children, and earlier studies have linked its changes to repeated muscle breakdown during periods of stress. This report fits that pattern and adds a new variant to the list of known changes, which helps expand understanding of how different LPIN1 changes may affect people.
The paper’s focus on the role of genetic testing matches broader medical guidance that recurrent, unexplained muscle breakdown deserves a genetic evaluation. This case supports that approach while adding a detailed example of how the testing changed the understanding of one child’s condition.
The most important limitation is that this report describes only one child. A single case cannot show how often this change occurs, how severe it is in most people, or whether it would respond the same way to treatment in others.
The report does not include a comparison group, so it cannot prove that the gene change caused every symptom. Other factors, such as infections or other health conditions, may have contributed, although the authors connect the change to the child’s pattern of episodes.
Long-term outcomes, such as kidney health years later, are not described. The paper also does not detail testing of family members, and the 60% figure is drawn from earlier research in Western populations rather than from this child’s data. Results may not apply to children in other regions or with different backgrounds.
The Bottom Line
High confidence: Recurrent, unexplained episodes of rhabdomyolysis in a child should prompt a medical evaluation, including blood and kidney tests and, when appropriate, genetic testing. Moderate confidence: LPIN1 gene testing is a sensible step for children with repeated episodes, especially when illness or fasting seems to trigger them. Low confidence: Based on this single case, the exact share of people who carry this specific variant, or how well it responds to particular treatments, remains unknown.
Parents of children with repeated muscle pain, dark urine, or weakness should discuss these symptoms with a doctor. Pediatricians, neurologists, kidney specialists, and genetic counselors will find this report useful for understanding recurrent cases. Adults with no history of muscle breakdown and children with no symptoms do not need to act on this report. This article is not a tool for self-diagnosis.
Genetic test results often take several weeks to return, so the diagnosis may not be clear at the time of an emergency. Once a cause is identified, doctors can plan preventive steps, but this case report does not show how quickly those steps reduce episodes. Many people with recurrent muscle breakdown need ongoing care and monitoring over months to years, so expectations should be discussed with a specialist.
Frequently Asked Questions
What is rhabdomyolysis in children?
Rhabdomyolysis is a serious condition in which damaged muscle breaks down and releases proteins such as myoglobin and creatine kinase into the blood. It can cause dark urine, severe muscle pain, and weakness, and it may strain the kidneys. Repeated episodes need prompt medical evaluation.
Can a gene change cause repeated muscle breakdown?
Changes in the LPIN1 gene may cause repeated muscle breakdown. A 2026 case report of a 9-year-old child linked a new LPIN1 change to more than 17 episodes. The report also notes that LPIN1 mutations account for about 60% of recurrent pediatric cases in Western cohorts.
How do doctors test for LPIN1 gene changes?
Doctors often use whole-exome sequencing, a genetic test that reads the protein-coding parts of genes to look for disease-causing changes. According to a 2026 case report in Medicine, early genetic confirmation can guide treatment and prevention strategies for recurrent rhabdomyolysis.
What should I do if my child has dark urine and severe muscle pain?
Seek medical care promptly, especially if urine is dark red or cola-colored, since these can signal muscle breakdown. Doctors may order blood tests for creatine kinase and kidney function. If episodes keep returning, they may recommend genetic testing to look for an underlying cause.
Want to Apply This Research?
- Log each episode of dark urine, muscle pain (rated 0 to 10), weakness, vomiting, and fever, along with the date and any recent illness. Track the number of episodes per month and the number of days each one lasts. Also record long gaps between meals and days with low fluid intake, since these may be linked to episodes.
- Use the app to set reminders for regular meals and steady fluid intake, especially during illness. Set an alert that prompts you to contact a doctor right away if urine turns dark red or cola-colored. Review the log with your care team before making any major diet or exercise changes.
- Keep the episode log for at least 12 months to show patterns over time. Share the log at every medical visit so the care team can spot trends in frequency and severity. Note any kidney-related symptoms or test results, and update the log if a genetic result or new diagnosis is received.
This article summarizes a single case report and is for general information only. It is not medical advice and does not replace care from a qualified doctor. Anyone with dark urine, severe muscle pain, weakness, or vomiting should seek urgent medical attention. Genetic results should be interpreted by a clinician or genetic counselor.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.